SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-23-022546
Filing Date
2023-12-14
Accepted
2023-12-14 08:38:15
Documents
7
Period of Report
2023-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 8042
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 229997
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 683369
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 7396
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 6810
6 GRAPHIC exhibit99-1x001.jpg GRAPHIC 2829
7 GRAPHIC exhibit99-2x001.jpg GRAPHIC 10242
  Complete submission text file 0001062993-23-022546.txt   954893
Mailing Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6
Business Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-39530 | Film No.: 231485688
SIC: 2834 Pharmaceutical Preparations